Search results for " industry 4.0" in Articles / App Notes
Article
Implementation of Process Intensification Strategies Across the Entire Cell Culture Workflow
This presentation will describe strategies to intensify upstream operations. Andreas Castan, Strategic Technology Collaborations Leader at Cytiva, will discuss the latest trends across the indu…
Article
The Future of Biopharma
In this article, Günter Jagschies, former Senior Director, Strategic Consumer Relations at Cytiva, highlights the evolution of the biopharma industry. Günter discuss challenges and opportunities for…
Article
Can Vaccine Development Be Safely Accelerated?
Can Vaccine Development Be Safely Accelerated?
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
By Cynthia A. Ch…
Article
Mapping a Route for Cell and Gene Therapy Process Development
While cell and gene therapies differ in many ways, some of the best practices for process development and validation are similar.
By Cynthia A. Challener
…
Article
Securing Today’s Biomanufacturing Supply Chain Using Transformative Supply
Today, biologics represent a $250 billion industry, which is two times what it was worth only 10 years ago. Though monoclonal antibodies are expected to continue dominating the market, a more divers…
Article
Next Generation Bioprocesses: Mapping Roads to the Future
Increased productivity demand and a diversifying clinical drug pipeline have pushed the industry to explore new strategies and technologies in biomanufacturing. So what are next-generation proc…
Article
Cytiva and NIBRT Join Forces to Boost Talent Growth in Single-Use Bioprocessing
Cytiva and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland, are combining their expertise to deliver educational programming on biopharmaceutical and cell th…
Article
Intensified Chromatography Strategies
The blockbuster drug era is over and drug manufacturers are now striving for a more diversified portfolio by targeting a greater number of monoclonal antibody (mAb) products at lower production volu…
Article
Sephadex™ Size Exclusion Resin Turns 60
Do you know the story behind Sephadex, which enabled today's large-scale production of biopharmaceuticals? An inadvertent discovery in 1959 became the foundation for today's biopharma industry. This i…
Article
What’s New in Upstream Technologies
Recent upstream processing innovations include enhanced sensor technology, single-use bioreactors, and automated cell culture systems.
By Amber Lowry
SCIENCE PHOTO - STOCK.A…